Health Conditions

Prognosis

The predicted course and outcome of a disease — including likelihood of recovery, expected survival time, and probable quality of life. Prognosis depends on the specific condition, its stage and severity, available treatments, and the individual patient's response.

Prognosis (from Greek prognosis, “foreknowledge”) is the medical estimate of a disease’s probable course and outcome. It answers the questions owners most urgently need answered: How serious is this? What should we expect? How long does my dog have?

How Prognosis Is Determined

Prognostic estimates come from population-level data — studies of many dogs with the same condition, treated in similar ways, followed over time. Key metrics include:

  • Median survival time (MST): the time point at which 50% of studied dogs have died. Not a prediction for any individual dog — some survive much longer, some shorter.
  • Survival rate: percentage of dogs alive at a defined time point (e.g., “1-year survival rate of 60%”)
  • Disease-free interval: time from treatment to disease recurrence
  • Quality of life: increasingly recognized as equally important to survival duration

Factors That Influence Prognosis

  • Diagnosis: the specific condition matters enormously. Lymphoma treated with chemotherapy has a median survival of 10-14 months; hemangiosarcoma treated with surgery and chemotherapy has a median survival of 4-6 months.
  • Stage: earlier-stage disease generally carries better prognosis than advanced-stage
  • Grade: low-grade tumors tend to behave less aggressively than high-grade
  • Location: tumor location can determine surgical accessibility and functional impact
  • Response to treatment: initial treatment response is often the strongest prognostic indicator
  • ** health**: dogs with significant comorbidities face compounded challenges
  • Age: very young and very old dogs may tolerate certain treatments differently
  • Breed: some conditions have breed-specific prognostic patterns
  • Body condition: lean dogs tend to tolerate treatment and recover better than obese dogs
  • Treatment aggressiveness: multimodal treatment (surgery + chemotherapy + radiation) often improves outcomes compared to single-modality approaches
  • Completeness of surgery: clean surgical margins improve prognosis for many tumors
  • Owner compliance: consistency with medication, follow-up, and monitoring protocols

Interpreting Prognostic Information

Important principles for owners:

  • Median survival time is not a deadline. It is a statistical midpoint. Your dog might be in the 50% that lives longer.
  • Population data does not predict individual outcomes. Your dog’s response to treatment, overall health, and specific disease characteristics matter.
  • Prognosis can change. Initial estimates may improve with positive treatment response or worsen with disease progression.
  • Quality of life matters as much as duration. A prognosis should inform not just “how long” but “how well” — whether the expected remaining time will be comfortable and meaningful.

Discussing prognosis with your veterinarian is an ongoing conversation, not a one-time pronouncement. Treatment response, monitoring data, and quality-of-life assessment should refine the prognostic picture over time.